Durect Corp (FRA:DC8A)
€ 0.81 -0.015 (-1.88%) Market Cap: 25.87 Mil Enterprise Value: 29.05 Mil PE Ratio: 0 PB Ratio: 22.56 GF Score: 60/100

Q2 2020 DURECT Corp Earnings Call Transcript

Aug 03, 2020 / 08:30PM GMT
Release Date Price: €17.2 (-1.15%)
Operator

Greetings, and welcome to the DURECT Corporation Second Quarter 2020 Earnings Conference Call.

(Operator Instructions)

As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Mike Arenberg, Chief Financial Officer. Please go ahead, sir.

Michael H. Arenberg
DURECT Corporation - CFO & Secretary

Good afternoon, and welcome to our second quarter 2020 earnings conference call. This is Mike Arenberg, Chief Financial Officer of DURECT Corporation. I'll provide a brief review of our financial results; and then Jim Brown, our President and CEO, will provide an update on our program. We will then open up the call for a question-and-answer session.

Before beginning, I would like to remind you of our safe harbor statement. During the course of this call, we may make forward-looking statements regarding DURECT's products and development, expected product benefits, our product development plans, future clinical trials or projected financial results. These forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot